Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bo Xu, professor
Fuwai Hospital Chinese Academy of Medical Sciences (CAMS)
Study Chair - Shubin Qiao, professor
Fuwai Hospital Chinese Academy of Medical Sciences (CAMS)
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing Anzhen Hospital Capital Medical University
Beijing, Beijing Municipality, China
- Beijingchao-Yanghospital
Beijing, Beijing Municipality, China
- Fuwai Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
- Fujian Provincial Hospital
Fuzhou, Fujian, China
- Nanfang Hospital
Guangzhou, Guangdong, China
- the Frist Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
- Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China
- the People'S Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China
- Zhongshan People'S Hospital
Zhongshan, Gunagdong, China
- Cangzhou Central Hospital
Cangzhou, Hebei, China
- Tangshan Gongren Hospital
Tangshan, Hebei, China
- the First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China
- Xiangya Hospital Central South University
Changsha, Hunan, China
- the Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
- the Second Hospital of Jilin University
Changchun, Jilin, China
- the First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China
- Qilu Hospital of Shandong University
Jinan, Shandong, China
- Liaocheng People'S Hospital
Liaocheng, Shandong, China
- Shanghai Dongfang Hospital
Shanghai, Shanghai Municipality, China
- Shanghai Sixth People'S Hospital
Shanghai, Shanghai Municipality, China
- Tangdu Hospital-Fourth Military Medical University
Xi’an, Shanxi, China
- Inner Mongolia Autonomous Region People'S Hospital
Hohhot, The Inner Mongolia Autonomous Region, China
- Taida International Cardioascular Hospital
Tianjin, Tianjin Municipality, China
- Sir Run Run Shaw Hospital (srrsh), Affiliated With the Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- the First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2017
- Primary completion
- 30 Aug 2020
- Completion
- 30 Aug 2024
- Last update posted
- 21 Nov 2019
- Registered enrollment
- 431
- Registry id
- NCT03284255
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.